In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter

Virology

Volumn 295, Issue 1, 2002, Pages 86-96

  Laras, Andreas ^a   Koskinas, John ^a   Hadziyannis, Stephanos J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; RNA TRANSCRIPTION; STOP CODON; UNINDEXED SEQUENCE; VIRUS CORE; VIRUS MUTATION; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 0036058945     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1352     Document Type: Article

References (49)

1. Identification of three essential regions of hepatitis B virus X protein for trans-activation function
2. A mutations in the basic core promoter of hepatitis B virus isolated from Black Africans with hepatocellular carcinoma compared with asymptomatic carriers
3. Two core promoter mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication
4. Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression
5. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication
6. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection
7. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen serocon-version
8. Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus
9. Cell type-dependent regulation of the activity of the negative regulatory element of the hepatitis B virus core promoter
10. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli
11. The molecular biology of the hepatitis B viruses
12. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease
13. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) → T, A(1762) → T and G(1764) → A mutations in the core promoter
14. Naturally occurring variants of hepatitis B virus
15. Hepatitis B e antigen negative chronic hepatitis B: From clinical recognition to pathogenesis and treatment
16. Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B
17. Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma
18. Clinical relevance of hepatitis B viral mutations
19. Histological grading and staging of chronic hepatitis
20. Hepatitis B virus X gene 1751 to 1764 mutations: Implications for HBeAg status and disease
21. Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B
22. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients
23. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B
24. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation
25. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers
26. Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome
27. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal Proc
28. Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: Trans-activation and repression by CCAAT/enhancer binding protein
29. Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation
30. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections
31. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes
32. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen
33. A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B
34. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter
35. Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function
36. Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area
37. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis
38. Transcription control of hepadnavirus gene expression
39. The complete nucleotide sequence of hepatitis B virus in 9 patients with fulminant hepatitis B infection
40. Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins
41. Molecular heterogeneity of e antigen polypeptides in sera from carriers of hepatitis B virus
42. The precore/core promoter mutant (T1762 A1764) of hepatitis B virus: Clinical significance and an easy method for detection
43. Replication strategy of human hepatitis B virus
44. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA
45. Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated
46. Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily
47. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus
48. Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter
49. Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatoma cell lines